Abstract: Fibrous structures that exhibit a Geometric Mean Modulus (GM Modulus) of less than 1070 g/cm as measured according to the Modulus Test Method described herein and a Geometric Mean Elongation (GM Elongation or GM Elong) of less than 15% measured according to the Elongation Test Method described herein are provided.

Abstract: Methods and apparatus are provided for generating interrupts associated with the completion of data processing. An external host may pass a first data block to a first processing engine and later pass a second data block to a second processing engine. In typical implementations, the external host expects that processing of the first data block completes first. To prevent errors and faults on the part of the external host, an interrupt associated with the processing of the second data block completing first is collapsed onto the first data block.

Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.

Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to determine metastasis-free survival of breast cancer patients. The biomarkers can be detected by SELDI mass spectrometry in serum samples fractionated by means of anion exchange chromatography. Some of the biomarkers have been identified as: Apolipoprotein A1; Apolipoprotein A2; Haptoglobin alpha 1; Transferrin; Complement C3a; and truncated forms thereof.

Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.

Abstract: A multi-ply paper product having a first ply and a second ply. The first ply has a plurality of first surface features, the first surface features have a number density of from about 5/cm2 to about 20/cm2, a surface area of from about 0.3 mm2 to about 4 mm2, and a height of from about 600 microns to about 2500 microns. The second ply has a plurality of second surface features with a number density of from about 30/cm2 to about 80/cm2, a surface area of from about 0.03 mm2 to about 1.2 mm2, and a height of from about 400 microns to about 1600 microns.

Abstract: The present invention relates to the identification and use of polypeptides that bind to antibodies directed to a desired polypeptide of interest. Using natriuretic peptides and their precursors, and in particular BNP, as an example, the present invention describes a number of natriuretic peptides fragments produced in biological samples, most preferably blood-derived samples, that bind to antibodies directed to BNP. Because production of such fragments is an ongoing process that may be a function of, inter alia, the elapsed time between onset of an event triggering natriuretic peptide release into the tissues and the time the sample is obtained or analyzed; the elapsed time between sample acquisition and the time the sample is analyzed; the type of tissue sample at issue; the storage conditions; the quantity of proteolytic enzymes present; etc.

Abstract: The present invention relates to the identification and use of polypeptides that bind to antibodies directed to a desired polypeptide of interest. Using natriuretic peptides and their precursors, and in particular BNP, as an example, the present invention describes a number of natriuretic peptides fragments produced in biological samples, most preferably blood-derived samples, that bind to antibodies directed to BNP. Because production of such fragments is an ongoing process that may be a function of, inter alia, the elapsed time between onset of an event triggering natriuretic peptide release into the tissues and the time the sample is obtained or analyzed; the elapsed time between sample acquisition and the time the sample is analyzed; the type of tissue sample at issue; the storage conditions; the quantity of proteolytic enzymes present; etc.

Abstract: Methods and apparatus are provided for generating interrupts associated with the completion of data processing. An external host may pass a first data block to a first processing engine and later pass a second data block to a second processing engine. In typical implementations, the external host expects that processing of the first data block completes first. To prevent errors and faults on the part of the external host, an interrupt associated with the processing of the second data block completing first is collapsed onto the first data block.